Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Klichinsky currently holds 56,982 shares of Carisma Therapeutics Inc. (CARM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Klichinsky has been a net seller of CARM stock. They have purchased $0 and sold $138.2K worth of shares.
Michael Klichinsky's most recent insider trade was on Oct 7, 2025, when they sold 56,982 shares at $0.11 per share.
Michael Klichinsky serves as Executive at Carisma Therapeutics Inc. (CARM). They have executed 8 insider transactions totaling $138.2K over their tenure at the company.
Michael Klichinsky holds the position of Executive at Carisma Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Michael Klichinsky has shown a selling trading pattern, with $0 in total purchases and $138.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Klichinsky was on Oct 2, 2025, when they sold $50.0K worth of CARM shares. This transaction involved 200,000 shares at $0.25 per share.
Michael Klichinsky currently owns 56,982 shares of Carisma Therapeutics Inc. (CARM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Klichinsky's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Klichinsky has 8 Form 4 filings on record as an insider at Carisma Therapeutics Inc..
Set alerts for Michael Klichinsky and 40,000+ other insiders.